VSee Health Launches AI-Driven Telehealth Program to Combat Maternal Mortality in Rural Philippines

SAN JOSE, Calif.--(BUSINESS WIRE)--VSee Health, Inc. (Nasdaq: VSEE), a pioneering company in digital health solutions, has launched Project MAMA (Mom's AI for Maternity Aid) to tackle high maternal mortality rates in the remote regions of Zamboanga Sibugay, Philippines. This groundbreaking telehealth initiative aims to provide essential prenatal care to women in underserved areas who have often never received an ultrasound or been seen by an obstetrician-gynecologist (OB-GYN). In collaboration with maternal care experts from Stanford University and Ateneo de Zamboanga University, VSee has successfully deployed a comprehensive telehealth platform that includes AI chatbots, portable diagnostic devices, and electronic health records (EHRs). The AI chatbots communicate in local languages, ensuring that language barriers do not hinder access to care. Portable ultrasound devices and EHRs further enhance the program's capabilities, allowing for thorough and efficient remote consultations. "Project MAMA underscores our dedication to closing the global healthcare gap using cutting-edge technology," said Dr. Milton Chen, PhD, co-CEO of VSee Health. "By providing high-quality prenatal care, we are making a significant impact on the lives of mothers who, until now, have lacked access to vital medical services. We are also exploring how AI can help predict and mitigate the risk of maternal mortality by analyzing patient data trends." This pilot program not only addresses immediate healthcare needs in rural Philippines but also serves as a model for VSee's broader mission to bring accessible healthcare to underserved populations around the world. The rapid deployment of the telehealth platform—fully operational within just four days—demonstrates the company's agility and commitment to making a tangible difference quickly. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements, often marked by words like "believes," "expects," "plans," "estimates," "assumes," "may," "should," or "will," reflect the company's current expectations and projections about future events. Actual outcomes may vary due to various risks and uncertainties, including those detailed in VSee Health's most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q, which are available on the SEC’s website at www.sec.gov. The company does not undertake any obligation to update these forward-looking statements in light of new information or future developments. Readers are advised to exercise caution when relying on forward-looking statements. About VSee Health VSee Health (Nasdaq: VSEE) is a leading company in AI-powered telehealth, reshaping the $787 billion digital healthcare market with its flexible, no-code/low-code platform. Trusted by over 1,000 clients, including NASA, the U.S. Department of Health and Human Services, McKesson, DaVita, and the nation of Qatar, VSee Health offers robust infrastructure and turnkey solutions to streamline healthcare operations, increase patient interaction, and enhance provider efficiency. For more information, visit vseehealth.com. More News From VSee Health, Inc.